These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10691167)

  • 1. Metformin: a useful adjunct to insulin therapy?
    Bailey CJ
    Diabet Med; 2000 Jan; 17(1):83-4. PubMed ID: 10691167
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes control without weight gain.
    Health News; 1999 Apr; 5(5):6. PubMed ID: 10214130
    [No Abstract]   [Full Text] [Related]  

  • 3. Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.
    Out M; Miedema I; Jager-Wittenaar H; van der Schans C; Krijnen W; Lehert P; Stehouwer C; Kooy A
    Diabetes Obes Metab; 2018 Jan; 20(1):219-223. PubMed ID: 28681986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.
    Mäkimattila S; Nikkilä K; Yki-Järvinen H
    Diabetologia; 1999 Apr; 42(4):406-12. PubMed ID: 10230643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of drugs in the management of diabetes mellitus.
    Das S
    J Indian Med Assoc; 2002 Jul; 100(7):434, 436, 445-7. PubMed ID: 12674168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
    Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin therapy in type II diabetes.
    Holman RR; Turner RC
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S179-84. PubMed ID: 8529512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus.
    Yki-Järvinen H; Nikkilä K; Mäkimattila S
    Drugs; 1999; 58 Suppl 1():53-4; discussion 75-82. PubMed ID: 10576526
    [No Abstract]   [Full Text] [Related]  

  • 10. Metformin as adjuvant to insulin therapy in type 2 diabetic patients.
    Vanamo R
    Diabetes Care; 1999 Mar; 22(3):528. PubMed ID: 10097944
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin use as an adjunct to insulin treatment.
    Gunton JE; Twigg SM
    Med J Aust; 2003 Jun; 178(11):591-2. PubMed ID: 12765513
    [No Abstract]   [Full Text] [Related]  

  • 12. [Insulin resistance in type 2 diabetes patients].
    Chodorowski Z; Sein Anand J; Cylkowska B; Hajduk A; Kujawska-Danecka H
    Przegl Lek; 2007; 64(4-5):368-9. PubMed ID: 17724917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Avilés-Santa L; Sinding J; Raskin P
    Ann Intern Med; 1999 Aug; 131(3):182-8. PubMed ID: 10428734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-metformin combination therapy in obese patients with type 2 diabetes.
    Jaber LA; Nowak SN; Slaughter RR
    J Clin Pharmacol; 2002 Jan; 42(1):89-94. PubMed ID: 11808829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting the Gordian knot. Addition of metformin to insulin therapy in a patient with uncontrolled diabetes and schizophrenia.
    McDonnell ME; Ruderman NB
    Diabetes Care; 1999 Nov; 22(11):1912-3. PubMed ID: 10546035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of insulin and metformin in the treatment of type 2 diabetes.
    Wulffelé MG; Kooy A; Lehert P; Bets D; Ogterop JC; Borger van der Burg B; Donker AJ; Stehouwer CD
    Diabetes Care; 2002 Dec; 25(12):2133-40. PubMed ID: 12453950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients: response to Poulsen et al.
    Mikhail N
    Diabetes Care; 2004 Jul; 27(7):1846-7; author reply 1847-8. PubMed ID: 15220287
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.
    Fontbonne A; Charles MA; Juhan-Vague I; Bard JM; André P; Isnard F; Cohen JM; Grandmottet P; Vague P; Safar ME; Eschwège E
    Diabetes Care; 1996 Sep; 19(9):920-6. PubMed ID: 8875083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.